locktalksupportcardidcommercial

Reagents for environmental monitoring, bioassay, geochemistry, radiopharmacy and decommissioning

Reagents for environmental monitoring, bioassay, geochemistry, radiopharmacy and decommissioning 

Read more...

Our products

TrisKem is the leading European manufacturer and provider of highly specific resins for use in radiochemistry and metals separation. It further provides equipments and accessories used in radiochemical analysis

Expertise in Separation Chemistry

Identity: Strongly customer-oriented, TrisKem is dedicated to high quality development and production of innovative and ecologically responsible technologies

 

Conviction: We commit our competences and expertise in separation chemistry to solve complex challenges in analytical and radiochemistry, nuclear medicine, decommissioning, hydrometallurgy and other domains requiring highly selective solutions.

 

Vision: Our ambition is to become the global leader in developing and manufacturing products and solutions for complex inorganic separations from laboratory to semi industrial scale.

 

Reagents for environmental monitoring, bioassay, geochemistry, radiopharmacy and decommissioning

 

TrisKem International develops, produces and markets the reagents used for radioactivity analysis in environmental, medical, bioassay and waste matrices. TrisKem International markets radionuclide separation solutions and applications for nuclear medicine and radiopharmacy.

 

Our main products line of extraction chromatographic resins which allow the separation of radionuclides and elements from various samples and matrices (environmental, medical and bioassay samples, irradiated targets as well as waste samples).

 

Our products are a standard technology in radiochemistry used by international accredited laboratories and monitoring agencies.

 

TrisKem International is your R&D partner for developing new radiation protection and environmental pollution control processes. Read more...

Headlines

Updated versions of our TechDocs online

Updated versions of our TechDocs online

Updated versions of our three TechDocs (All Resins, New Developments/World Wide and Radiopharmacy) are online now!

Presentations and videos hybrid UGM 2023

Presentations and videos hybrid UGM 2023

PDF versions and video recordings of the presentations given at our 2023 hybrid Users Groupo Meeting are online now! We would like to once more thank all participents and presenters for the interesting contributions and discussion!

TrisKem Info N°23 online

TrisKem Info N°23 online

You will find the latest edition of our TrisKem Infos (TKI23) online. This edition is dedicated to our new TK102 Resin and our new autodeposition units

New poster added to poster section

New poster added to poster section

New poster: J. Svedjehed, M. Bas, S. Happel, K. Gagnon: New extractant-impregnated iTLC-SG paper facilitates improved TLC analysis for Cu radiolabelled peptides presented at the Terachem 2022 has been added to our poster session. The poster shows first results of upcoming CU Sheets

Pricelist 2023

Pricelist 2023

Our pricelist 2023 is now available upon request under: contact@triskem.fr! You will find that we have added several new products such as TK222/5 and TK102.

Users Group Meeting in York (UK)

Users Group Meeting in York (UK)

We would like to cordially thank all participants of our Users Group Meeting that took place on September 16 in York (UK) for all the great presentations and discussions! Very special thanks to Alex Tarancon Sanz, Phil Warwick, Hibaaq Mohamud and Matthew Higginson, for sharing their work with our Users and us! Presentations, including TrisKems news and new developments presented by Aude Bombard, Soumaya khalfallah and Illarion Dovhyi, are available on our website now

7th Theranostics World Congress

7th Theranostics World Congress

Visit us at our booth at the 7th Theranostics World Congress from March 22 - 24 in Santiago (Chile)

Subscribe to our newsletter to keep up to date with our latest developments

Subscribe

Social Wall

Subscribe to our newsletter to keep up to date with our latest developments